Dewpoint Therapeutics
Dewpoint Therapeutics is a biotechnology company applying the emerging science of biomolecular condensates to drug discovery. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional research site in Dresden, Germany, Dewpoint has built an AI-powered, end-to-end platform (ERSA, powered by ERSAi) spanning target discovery, condensate-modulating (c-mod) drug discovery, optimization, and development. Its pipeline targets previously undruggable diseases across oncology, neurodegeneration, cardiopulmonary, and virology, with collaborations including Bayer, Novo Nordisk, Evotec, and Chemify. Dewpoint is a General Catalyst portfolio company; it operates internal research platforms and the open CD-CODE condensate knowledge platform (condensates.com), but does not publish a public developer API.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Dewpoint Therapeutics is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Dewpoint Therapeutics scores 13.0/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Dewpoint Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Dewpoint Therapeutics is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/dewpoint-therapeutics · machine-readable index on apis.io